Lineage Cell Therapeutics LCTX
NYSE LCTX
$1.08 -0.02 (-1.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Lineage Cell Therapeutics (LCTX) Tax Rate (QoQ) (2014 - 2019)

Analysis

Lineage Cell Therapeutics (LCTX) Tax Rate (QoQ) (2014 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Lineage Cell Therapeutics 270.71 Mn 213.99 Mn 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 26,802.00
Sep 30, 2019 -183.00
Jun 30, 2019 -1,644.00
Sep 30, 2014 713.00
Jun 30, 2014 -45.00